Insider Buying Activity Uncovered - 7 Stocks On The Rise

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Detecting Cancer in 1.5 Seconds: Early Investment Opportunity]( [Learn more about how this could transform the multi-billion dollar diagnostic market.]( --------------------------------------------------------------- April 01, 2024 Editorial Insights Insider trading occurs when company executives or major shareholders trade stocks based on non-public information. Monitoring these trades provides insight into insiders' expectations for the company's future. For instance, significant purchases before public announcements may indicate anticipated positive news and a potential share price increase. Note: "Insider Buying" is legal stock purchasing by company directors or officers, distinct from illegal insider trading based on non-public information. It's not a crime when based on public information. Insiders, having unique insights, often buy shares when they believe the stock is undervalued. This report lists stocks recently identified with substantial insider buying. --------------------------------------------------------------- Sponsor Message [Game-Changing Cancer Tech Nears FDA Completion]( the world of tech advancements, a new player could outshine even AI. It's a revolutionary technology with the aim of transforming cancer detection. Imagine the leap from basic reading glasses to cutting-edge VR; that's the scale of innovation we're talking about. FDA review is in its final stages and it could become the gold standard before we know it. [Explore Investment Opportunities in This Market Disruptor]( --------------------------------------------------------------- [Nkarta, Inc.]( Ticker: [NKTX]( Recent Price: $10.81 Average Analyst Price Target: $19.33 (78.85%) Market Cap: $534.19M Role Transaction Description No. of Shares Amount Date Director, >10% Owner Informative Buy Non Open Market Buy 3,000,000 $30,000,000 4 Days Ago Director Informative Buy Non Open Market Buy 2,000,000 $20,000,000 5 Days Ago Recent Analyst Action: Yaron Werber, analyst at TD Cowen, reiterates coverage on [Nkarta, Inc. (NKTX)]( in the Healthcare sector with a Buy rating (5 days ago). Here are 3rd party ratings for [NKTX](: - TipRanks.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 31% (78 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Richest investors clearly worried about something big]( Dalio, John Paulson, and many others all recommend you own gold right now. But did you know there's another huge investor (worth more than all the world's billionaires COMBINED) buying gold by the ton? That's why the best move to make right now could be this little-known gold investment (which you can get started with for just $5.) [Click for full story.]( --------------------------------------------------------------- [OmniAb, Inc.]( Ticker: [OABI]( Recent Price: $5.42 Average Analyst Price Target: $9.25 (70.66%) Market Cap: $634.82M Role Transaction Description No. of Shares Amount Date President & CEO, Director Informative Buy Options Exercised and fully kept 243,613 $907,023 4 Days Ago Recent Analyst Action: Matt Hewitt, analyst at Craig-Hallum, reiterates coverage on [OmniAb, Inc. (OABI)]( in the Healthcare sector with a Buy rating (6 days ago). Here are 3rd party ratings for [OABI](: - TipRanks.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 37% (93 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- [Inspire Medical Systems, Inc.]( Ticker: [INSP]( Recent Price: $214.79 Average Analyst Price Target: $239.00 (11.27%) Market Cap: $6.35B Role Transaction Description No. of Shares Amount Date Director Informative Buy Options Exercised and fully kept 3,243 $294,633 4 Days Ago Recent Analyst Action: Travis Steed, analyst at Bank of America Securities, reiterates coverage on [Inspire Medical Systems, Inc. (INSP)]( in the Healthcare sector with a Buy rating and a price target of $265 (1 week ago). Here are 3rd party ratings for [INSP](: - TipRanks.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Buy, Top 35% (88 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [GPT-4 vs. X.AI: The Race of the New AI Giants]( smart money investors all know AI is the wave of the future and could mean huge profits for anyone involved. AI has been called the biggest new industry of the 21st century. Experts are projecting it will be worth a staggering $80 trillion over the next 10 years. And right now, Chief Investment Strategist Adam O’Dell is revealing his favorite X.AI stock you should check out today. [Click here to see the full story now.]( --------------------------------------------------------------- [Organogenesis Holdings Inc.]( Ticker: [ORGO]( Recent Price: $2.84 Average Analyst Price Target: $4.67 (64.32%) Market Cap: $374.77M Role Transaction Description No. of Shares Amount Date COO Informative Buy Options Exercised and fully kept 152,250 $179,655 4 Days Ago Recent Analyst Action: Ryan Zimmerman, analyst at BTIG, reiterates coverage on [Organogenesis Holdings Inc. (ORGO)]( in the Healthcare sector with a Buy rating and a price target of $6 (1 week ago). Here are 3rd party ratings for [ORGO](: - TipRanks.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Sell, Top 37% (93 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- [CommScope Holding Company, Inc.]( Ticker: [COMM]( Recent Price: $1.31 Average Analyst Price Target: $1.25 (-4.58%) Market Cap: $278.08M Role Transaction Description No. of Shares Amount Date EVP & CFO Informative Buy Non Open Market Buy 11,600 $14,500 4 Days Ago Recent Analyst Action: Tal Liani, analyst at Bank of America Securities, reiterates coverage on [CommScope Holding Company, Inc. (COMM)]( in the Technology sector with a Sell rating and a price target of $1 (2 weeks ago). Here are 3rd party ratings for [COMM](: - TipRanks.com: Hold - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Top 38% (96 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Imminent FDA Decision Could End Obesity in America...]( [...and spark a 224,000% sales surge for one tiny micro-cap stock.]( The Wall Street Journal Reports: The "King Kong" of drugs is coming. Barron's Reports: "it's game changing." [Get the name of the stock here ]( --------------------------------------------------------------- [Vericel Corporation]( Ticker: [VCEL]( Recent Price: $52.02 Average Analyst Price Target: $51.10 (-1.77%) Market Cap: $2.51B Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 235 $12,260 2 Days Ago Recent Analyst Action: Samuel Brodovsky, analyst at Truist Financial, reiterates coverage on [Vericel Corporation (VCEL)]( in the Healthcare sector with a Buy rating (5 days ago). Here are 3rd party ratings for [VCEL](: - TipRanks.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 31% (78 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- [Rocket Companies, Inc.]( Ticker: [RKT]( Recent Price: $14.55 Average Analyst Price Target: $10.60 (-27.15%) Market Cap: $28.89B Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 301 $4,386 4 Days Ago Director Informative Buy Non Open Market Buy 622 $8,742 6 Days Ago Recent Analyst Action: Mihir Bhatia, analyst at Bank of America Securities, reiterates coverage on [Rocket Companies, Inc. (RKT)]( in the Financial Services sector with a Sell rating and a price target of $8 (1 week ago). Here are 3rd party ratings for [RKT](: - TipRanks.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 33% (82 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- And there you have it. To Your Financial Freedom, The Editor MarketSectorDaily.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be third-party advertisements where the advertiser is paying per click, per lead, or per sale and are not endorsed or warranted by our staff or company. SPMG, MarketSectorDaily.com and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged not to use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. SPMG, MarketSectorDaily.com nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from SPMG or MarketSectorDaily.com to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to MarketSectorDaily.com MarketSectorDaily.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Mt. Mourne | North Carolina | 28123 | United States | 8774119808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software